Cargando…

A long-acting β(2)-adrenergic agonist increases the expression of muscarine cholinergic subtype-3 receptors by activating the β(2)-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells

The persistent administration of β(2)-adrenergic (β(2)AR) agonists has been demonstrated to increase the risk of severe asthma, partly due to the induction of tolerance to bronchoprotection via undefined mechanisms. The present study investigated the potential effect of the long-acting β(2)-adrenerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, YUAN-HUA, WU, SONG-ZE, WANG, GANG, HUANG, NI-WEN, LIU, CHUN-TAO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394984/ https://www.ncbi.nlm.nih.gov/pubmed/25672589 http://dx.doi.org/10.3892/mmr.2015.3307

Ejemplares similares

Involvement of Ca(2+) Signaling in the Synergistic Effects between Muscarinic Receptor Antagonists and β(2)-Adrenoceptor Agonists in Airway Smooth Muscle
por: Fukunaga, Kentaro, et al.
Publicado: (2016)

M2 Muscarinic Receptor-Dependent Contractions of Airway Smooth Muscle are Inhibited by Activation of β-Adrenoceptors
por: Alkawadri, Tuleen, et al.
Publicado: (2022)

β(2)-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro
por: Luo, Jian, et al.
Publicado: (2017)

Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors
por: Frazier, Elfaridah P., et al.
Publicado: (2007)

β(2)‐Adrenoceptor agonist activity of higenamine
por: Hudzik, Thomas J., et al.
Publicado: (2021)

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()
por: Dale, Philippa R, et al.
Publicado: (2014)

Retraction Note: β(2)-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro
por: Luo, Jian, et al.
Publicado: (2019)

Paradoxical bronchoconstriction caused by β(2)-adrenoceptor agonists
por: Ayed, Khadija, et al.
Publicado: (2020)

CYCLIC ADENOSINE MONOPHOSPHATE IN PHAGOCYTIZING GRANULOCYTES AND ALVEOLAR MACROPHAGES
por: Seyberth, H. W., et al.
Publicado: (1973)

Structure and Function of an Irreversible Agonist-β(2) Adrenoceptor complex
por: Rosenbaum, Daniel M., et al.
Publicado: (2011)

Functional desensitization of the β(2) adrenoceptor is not dependent on agonist efficacy
por: Rosethorne, Elizabeth M, et al.
Publicado: (2015)

A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)

Involvement of β‐adrenoceptors in the cardiovascular responses induced by selective adenosine A(2A) and A(2B) receptor agonists
por: Wragg, Edward S., et al.
Publicado: (2022)

The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways
por: Jude, Joseph Antony, et al.
Publicado: (2023)

Postreceptor signal transduction by cyclic adenosine monophosphate and the Ca2+-calmodulin complex
por: Means, A. R., et al.
Publicado: (1984)

Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
Publicado: (1979)

Downregulation of cyclic adenosine monophosphate levels in leukocytes of hibernating captive black bears is similar to reported cyclic adenosine monophosphate findings in major depressive disorder
por: Tsiouris, John A., et al.
Publicado: (2023)

Involvement of Allosteric Effect and K(Ca) Channels in Crosstalk between β(2)-Adrenergic and Muscarinic M(2) Receptors in Airway Smooth Muscle
por: Kume, Hiroaki, et al.
Publicado: (2018)

EFFECT OF ADENOSINE 3'-5'-CYCLIC MONOPHOSPHATE ON CELL PROLIFERATION
por: Froehlich, Jeffrey E., et al.
Publicado: (1972)

The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation
por: Rundfeldt, Chris, et al.
Publicado: (2012)

Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists
por: Senthil Kumar, P., et al.
Publicado: (2009)

A Novel Adenosine Precursor 2′,3′-Cyclic Adenosine Monophosphate Inhibits Formation of Post-surgical Adhesions
por: Forman, Mervyn B., et al.
Publicado: (2014)

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

Rubus occidentalis and Ellagic Acid Affect the Contractility of Penile Corpus Cavernosum Smooth Muscle through the Nitric Oxide-Cyclic Guanosine Monophosphate and Cyclic Adenosine 3′,5′-Monophosphate Signaling Pathway
por: Karna, Keshab Kumar, et al.
Publicado: (2022)

17β-Estradiol Concentration and Direct β(2)-Adrenoceptor Inhibition Determine Estrogen-Mediated Reversal of Adrenergic Immunosuppression
por: Priyanka, Hannah P., et al.
Publicado: (2022)

The Clinical Correlation of Regulatory T Cells and Cyclic Adenosine Monophosphate in Enterovirus 71 Infection
por: Wang, Shih-Min, et al.
Publicado: (2014)

Antibody-induced changes in levels of cyclic adenosine monophosphate in leukaemic lymphocytes.
por: Virji, M., et al.
Publicado: (1979)

Fear renewal activates cyclic adenosine monophosphate signaling in the dentate gyrus
por: Shi, Yan-Wei, et al.
Publicado: (2019)

Visualizing Cyclic Adenosine Monophosphate in Cardiac Microdomains Involved in Ion Homeostasis
por: Dikolayev, Vladimir, et al.
Publicado: (2019)

The role of bacterial cyclic di-adenosine monophosphate in the host immune response
por: Cheng, Xingqun, et al.
Publicado: (2022)

Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
por: Zhao, Jie, et al.
Publicado: (2021)

The long-acting β(2)-adrenoceptor agonist olodaterol attenuates pulmonary inflammation
por: Wex, Eva, et al.
Publicado: (2015)

Cyclic Guanosine Monophosphate–Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing
por: Verrier, Eloi R., et al.
Publicado: (2021)

Does coupling to ADP ribosylation factor 6 explain differences between muscarinic and other receptors in interaction with β-adrenoceptor-mediated smooth muscle relaxation?
por: Erdogan, Betül R., et al.
Publicado: (2022)

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
por: Yamada, Hideyasu, et al.
Publicado: (2018)

Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia—Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate
por: Kuzmiszyn, Adrina Kalasho, et al.
Publicado: (2022)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

On the Site and Mechanism of Action of β(3)-Adrenoceptor Agonists in the Bladder
por: Andersson, Karl Erik
Publicado: (2017)

Effects of (a Combination of) the Beta(2)-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction
por: Maarsingh, Harm, et al.
Publicado: (2021)

Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancers.
por: Ramage, A. D., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_8o78ivuge010lc8bfaljqhfsbg